Oscar Health, Inc.
OSCR
$12.03
-$0.32-2.59%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.39B | 2.42B | 2.21B | 2.14B | 1.43B |
| Total Other Revenue | 4.81M | 4.90M | 5.23M | 5.63M | 5.72M |
| Total Revenue | 2.39B | 2.42B | 2.22B | 2.14B | 1.43B |
| Cost of Revenue | 2.07B | 2.00B | 1.71B | 1.55B | 1.21B |
| Gross Profit | 327.32M | 419.50M | 510.62M | 587.53M | 226.42M |
| SG&A Expenses | 465.82M | 460.38M | 435.21M | 394.16M | 364.15M |
| Depreciation & Amortization | 9.23M | 7.50M | 7.60M | 7.81M | 7.74M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.54B | 2.47B | 2.15B | 1.96B | 1.58B |
| Operating Income | -147.73M | -48.37M | 67.81M | 185.56M | -145.48M |
| Income Before Tax | -153.69M | -52.31M | 60.95M | 178.48M | -150.64M |
| Income Tax Expenses | -404.00K | 2.08M | 4.64M | 996.00K | -806.00K |
| Earnings from Continuing Operations | -153.29M | -54.39M | 56.31M | 177.48M | -149.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -262.00K | -208.00K | -105.00K | -114.00K | -192.00K |
| Net Income | -153.55M | -54.60M | 56.21M | 177.37M | -150.03M |
| EBIT | -147.73M | -48.37M | 67.81M | 185.56M | -145.48M |
| EBITDA | -138.50M | -40.87M | 75.41M | 193.37M | -137.74M |
| EPS Basic | -0.62 | -0.22 | 0.24 | 0.77 | -0.66 |
| Normalized Basic EPS | -0.39 | -0.14 | 0.16 | 0.48 | -0.42 |
| EPS Diluted | -0.68 | -0.22 | 0.20 | 0.62 | -0.66 |
| Normalized Diluted EPS | -0.39 | -0.14 | 0.13 | 0.38 | -0.42 |
| Average Basic Shares Outstanding | 248.21M | 243.11M | 238.67M | 231.44M | 227.08M |
| Average Diluted Shares Outstanding | 248.21M | 243.11M | 303.97M | 293.80M | 227.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |